Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Aminobutyric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel leucine dehydrogenase mutants enable high-efficiency synthesis of unnatural amino acids with improved stability and conversion rates for scalable pharmaceutical manufacturing.
Patent CN105481703A enables high-purity S-2-aminobutanol via catalytic hydrogenation. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN118895266A reveals enzymatic synthesis of L-2-aminobutyric acid. Achieve >99% conversion with reduced environmental impact for levetiracetam production.
Patent CN116064451B reveals high-activity transaminase mutant. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable enzymatic processes.
Patent CN101603063A reveals immobilized cell enzymatic method for L-2-amino fatty acid. High yield, scalable process for pharmaceutical intermediates supply chain optimization.
Novel HCl-based ring-opening chlorination method for (S)-4-chloro-2-aminobutyrate. Reduces thionyl chloride waste, improves yield, ensures scalable supply for glufosinate synthesis.
Novel asymmetric conversion method boosts yield to over 80 percent for L-2-aminobutyric acid, offering cost-effective pharma intermediate supply.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Novel enzymatic method for L-2-aminobutyric acid production. Low cost, high yield, scalable process for pharmaceutical intermediates and supply chain optimization.
Novel Strecker synthesis route for high-purity 2-aminobutyric acid. Reduces cost and impurities for Levetiracetam production via scalable n-propanal pathway.